Previous Close | 13.01 |
1-Year Change | -0.61% |
6-Months Change | 21.25% |
3-Months Change | 19.36% |
Moving Avg (50d) | 11.163 |
Moving Avg (200d) | 11.601 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 1.68B |
Beta (3-Years) | 1.18 |
Revenue Growth (ttm) | -50.74% |
Net Profit Margin (ttm) | 16.92% |
Return On Assets (ttm) | 6.28% |
EPS (ttm) | 0.4 |
PE Ratio (ttm) | 32.52 |
Dividend Yield | % |
Asset Description: | Dynavax Technologies Corporation |
Predicted Direction: | Buy |
Signal Strength: | Buy |
Forecast Date: | 2024-10-29 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
12.75 | 12.36 | 12.099 | 11.709 | 11.059 | 10.408 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Biotechnology |
Country: | United States |